In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts

Gut

Volumn 42, Issue 5, 1998, Pages 735-743

  Taylor Robinson, S D ^a   Sargentoni, J ^a   Bell, J D ^a   Thomas, E L ^a   Marcus, C D ^a   Changani, K K ^a   Saeed, N ^a   Hodgson, H J F ^a   Davidson, B R ^b   Burroughs, A K ^b   Rolles, K ^b   Foster, C S ^c   Cox, I J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Chronic ductopenic rejection; Electron microscopy; In vitro 31P magnetic resonance spectroscopy; In vivo 31P magnetic resonance spectroscopy; Liver transplantation; Phospholipids

Indexed keywords

GLYCEROPHOSPHOETHANOLAMINE; NUCLEOTIDE DERIVATIVE; ORGANOPHOSPHATE; PHOSPHATIDYLCHOLINE; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; PHOSPHORUS 31; PHOSPHORYLCHOLINE;

ADULT; AGED; ARTICLE; BILE DUCT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 7144261057     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.5.735     Document Type: Article

References (30)

1. Wiesner RH, Ludwig J, Krom RAF, et al. Hepatic allograft rejection: new developments in terminology, diagnosis, prevention and treatment. Mayo Clin Proc 1993;68:69-79.
2. Wiesner RH, Ludwig J, van Hoek B, et al. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991;14:721-9.
3. Noack KB, Wiesner RH, Batts K, et al. Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical and histological evidence for spontaneous resolution. Transplant Proc 1991;23:1448-51.
4. Hubscher SG, Buckels JAC, Elias E, et al. Vanishing bile-duct syndrome following liver transplantation - is it reversible? Transplantation 1991;51:1004-10.
5. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994;344:423-8.
6. Oberhaensli RD, Hilton Jones D, Bore PJ, et al. Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 1986;ii:8-11.
7. Cox IJ, Bryant DJ, Collins AG, et al. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J Comput Assist Tomogr 1988;12:369-76.
8. Meyerhoff DJ, Boska MD, Thomas AM, et al. Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy. Radiology 1989;173:393-400 (Erratum Radiology 1990;176:584).
9. 31P nuclear magnetic resonance spectroscopy. Clin Sci 1990;78:33-8.
10. Oberhaensli R, Rajagopalan B, Galloway GJ, et al. Study of human liver disease with P-31 magnetic resonance spectroscopy. Gut 1990;31:463-7.
11. Cox IJ, Menon DK, Sargentoni J, et al. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J Hepatol 1992;14:265-75.
12. 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed 1993;6:168-72.
13. Menon DK, Sargentoni J, Taylor-Robinson SD, et al. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 1995;21:417-27.
14. 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed 1992;5:114-20.
15. 1H NMR investigation in vitro of normal and abnormal human liver. Biochem Biophys Acta 1993;1225:71-7.
16. 31P nuclear magnetic resonance study. Biochim Biophys Acta 1995;1272: 113-8.
17. Murphy EJ, Brindle KM, Rorison CJ, et al. Changes in phosphatidylethanolamine metabolism in regenerating rat liver as measured by P-31 NMR. Biochem Biophys Acta 1992;1135:27-34.
18. Bailes DR, Bryant DJ, Bydder GM, et al. Localised phosphorus-31 NMR spectroscopy of normal and pathological human organs in vivo using phase encoding techniques. J Magn Reson 1987;74:158-70.
19. Ernst RR, Anderson WA. Application of fourier transform spectroscopy to magnetic resonance. Rev Sci Instrum 1966; 37:93.
20. Saeed N, Menon DK. A knowledge-based approach to minimise baseline roll in chemical shift imaging. Magn Reson Med 1993;29:591-8.
21. 31P magnetic resonance spectroscopy study. Br J Cancer 1993;67: 1303-9.
22. 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 1997;17: 198-209.
23. 31P signal. Magn Reson Med 1989;12:145-50.
24. Dawson RMC. Phosphorylcholine in rat tissues. Biochem J 1955;60:325-8.
25. Perry TL, Hansen S, Berry K, et al. Free amino acids and related compounds in biopsies of human brain. J Neurochem 1971;18:521-8.
26. Perry TL, Hansen S, Gandham SS. Post mortem changes of amino compounds in human and rat brain. J Neurochem 1981;36:406-12.
27. Rubin R, Munoz SJ. Clinicopathologic features of late hepatic dysfunction in orthotopic liver transplants. Hum Pathol 1993;24:643-51.
28. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992;5:226-33.
29. 31P NMR spectra in vivo. Magn Reson Med 1989;12:282-9.
30. Jalan R, Sargentoni J, Coutts GA, et al. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relationship to prognostic models. Gut 1996;39:141-6.